Chinese porcine joint venture received regulatory approval, triggering final $7.5M milestone payment from BCA to Genus.

British animal genetics company Genus expects to report full-year adjusted pretax profit "moderately above" the upper end of current market expectations, sending its shares as much as 15.3% higher on ...

Last September, Basingstoke-based Genus struck a deal to accelerate its 49%-owned porcine joint venture with BCA in China.

The Basingstoke, England-based animal biotechnology and genetics company said adjusted pretax profit for the six months to December 31 will be about GBP50 million, ahead of expectations. It will be ...

Genus is listed in the FTSE All-Share, FTSE 350 Low Yield, FTSE 250, FTSE 350 indices. Genus is listed in the Medicine and Biotech sector. Genus Plc Ord 10p is listed on the London Stock Exchange ...